• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Mengxue,ZHUANG Shentian,YANG Yong.Targeting B7-H4:a new strategy to overcome immunosuppressionand drug resistance in breast cancer[J].Journal Of Pharmaceutical Research,2025,44(6):576-579[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2135times   Download 786次 QR Code for this article
Scan with your phone!
靶向B7-H4:克服乳腺癌免疫抑制与耐药的新策略
张梦雪,庄申甜,杨勇
Font:Larger+|Default|Smaller-
(中国药科大学基础医学与临床药学学院,江苏 南京 211198)
摘要:
乳腺癌具有侵袭性强且复发率高的特点,已成为严重威胁女性健康的主要疾病。研究表明,B7-H4在人类大多数肿瘤组织中尤其是乳腺癌中异常高表达,与癌症进展和较差的临床预后密切相关。其不仅可以与T细胞上潜在的受体结合发挥免疫抑制作用,还可以增强肿瘤细胞自身的增殖、侵袭、转移、干性及抗凋亡能力,促进肿瘤的进展。但其调控机制尚不清楚,本文就在乳腺癌中B7-H4的研究进展进行综述,以期为未来研究提供新的方向。
关键词:  乳腺癌  B7-H4  免疫抑制  肿瘤免疫治疗
DOI:10.13506/j.cnki.jpr.2025.06.011
基金项目:国家自然科学基金青年科学基金项目(No.32301241)
Publication Date:June 25, 2025
Targeting B7-H4:a new strategy to overcome immunosuppressionand drug resistance in breast cancer
ZHANG Mengxue,ZHUANG Shentian,YANG Yong
(School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Breast cancer, characterized by its high invasiveness and recurrence rate, has emerged as a major disease that severely threatens women's health. Research indicates that B7-H4 is abnormally overexpressed in the majority of human tumor tissues, particularly in breast cancer, and is closely associated with cancer progression and poor clinical prognosis. It not only binds to potential receptors on T cells to exert immunosuppressive effects but also enhances the tumor cells' own capabilities in proliferation, invasion, metastasis, stemness, and anti-apoptosis, thereby promoting tumor progression. However, the regulatory mechanisms remain unclear. This article reviews the research progress on B7-H4 in breast cancer, aiming to provide new directions for future studies.
Key words:  Breast cancer  B7-H4  Immune evasion  Tumor immunotherapy
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.